| M | T | W | T | F | S | S |
|---|---|---|---|---|---|---|
| 1 | 2 | 3 | 4 | 5 | 6 | 7 |
| 8 | 9 | 10 | 11 | 12 | 13 | 14 |
| 15 | 16 | 17 | 18 | 19 | 20 | 21 |
| 22 | 23 | 24 | 25 | 26 | 27 | 28 |
| 29 | 30 | |||||
The AACR IO Conference 2026, titled Discovery and Innovation in Cancer Immunology: Revolutionizing Treatment through Immunotherapy, will take place from February 18–21, 2026, at JW Marriott Los Angeles L.A. Live.
Led by Scientific Committee Chairs Nina Bhardwaj and Antoni Ribas, the event will focus on cutting-edge research in cancer immunology, highlighting breakthroughs in immuno-oncology (IO) drugs, inflammatory modulators, vaccines, and cellular therapies.
Building on the success of AACR IO 2025, which drew over 600 participants, AACR IO 2026 promises a comprehensive program including keynote lectures, symposia, spotlight sessions, educational content, and poster presentations. This forum offers a valuable opportunity for scientists, clinicians, industry leaders, and advocates to engage with the latest advances in cancer immunotherapy.
More posts featuring AACR.
